More on XRTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.2 Score)
- Holders
- Dividends (17.5% Yield)

Upcoming Events

- Earnings (11/18/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

XORTX Therapeutics Inc (NQ:XRTX)
Delayed: 1.71 -0.02 (1.16%)
Prev. Close $1.73  
Open$1.72 
52 Wk High$13.52 
52 Wk Low$8.94 
Day High$1.79 
Day Low$1.70 
P/E N/A  
EPS$-0.27 
Volume4,475 

Friends, Peers and Foes (?): ANUA ANU (more...)

Sep 18, 2026 08:05 AM XORTX plans FDA IND filing for gout drug in Q4 2026
Sep 18, 2026 08:05 AM Form 6-K XORTX Therapeutics Inc. For: Sep 18
Sep 18, 2026 08:05 AM XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
Sep 10, 2026 04:18 PM Form 6-K XORTX Therapeutics Inc. For: Sep 10
Sep 10, 2026 04:07 PM XORTX begins manufacturing of gout drug candidate XORLO
Sep 10, 2026 04:05 PM XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
Sep 8, 2026 06:15 PM XORTX Re-Engages Investor Relations Program
Aug 28, 2026 07:01 AM XORTX cancels $2.5M investor relations deal, delays TSXV delisting
Aug 28, 2026 07:00 AM Form 6-K XORTX Therapeutics Inc. For: Aug 28
Aug 28, 2026 07:00 AM XORTX Announces Termination and Postponement of Investor Relations Program
View All Articles

Entities mentioned with XRTX

View All Entities